Clinical Trial Update: Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing pemetrexed plus carboplatin versus etoposide plus carboplatin in extensive-stage small cell lung cancer; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2009-10-06